Expression of tyrosine kinase receptor AXL is associated with worse outcome of metastatic renal cell carcinomas treated with sunitinib
Urologic Oncology: Seminars and Original Investigations | Oct 08, 2017
Sunitinib dose-escalation after disease progression in metastatic renal cell carcinoma
Urologic Oncology: Seminars and Original Investigations | Oct 04, 2017
Most read this week